LifeMD (LFMD) CTO receives 75,000-share time-vested stock grant

Rhea-AI Filing Summary

LifeMD, Inc. reported that Chief Technology Officer Sripad Umesh received an award of 75,000 shares of Common Stock as a grant or other acquisition. The award carries a zero dollar price per share, indicating it is compensation rather than an open-market purchase.

According to the footnote, this grant consists of restricted stock units that vest over time: 25,000 units on June 1, 2027, another 25,000 units on June 1, 2028, and the remaining units on June 1, 2029. Following this award, Umesh holds 75,000 shares directly, reflecting a new equity position that vests in stages over three years.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Sripad Umesh

Role Chief Technology Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	75,000	$0.00	--

Holdings After Transaction: Common Stock — 75,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Equity award size: 75,000 shares Grant price per share: $0.00 per share Post-transaction holdings: 75,000 shares +3 more

6 metrics

Equity award size 75,000 shares Grant of Common Stock to CTO Sripad Umesh

Grant price per share $0.00 per share Recorded transaction price for awarded shares

Post-transaction holdings 75,000 shares Shares directly held after the reported grant

Vesting on June 1, 2027 25,000 units First restricted stock unit vesting tranche

Vesting on June 1, 2028 25,000 units Second restricted stock unit vesting tranche

Final vesting on June 1, 2029 Remaining units Final restricted stock unit vesting tranche

Key Terms

restricted stock units, Common Stock, Grant, award, or other acquisition

3 terms

restricted stock units financial

"Grant of restricted stock units which vest 25,000 on June 1, 2027"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Common Stock financial

"security_title: "Common Stock" for the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sripad Umesh

(Last) (First) (Middle)

C/O LIFEMD, INC.

236 FIFTH AVENUE, SUITE 400

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		A		75,000	A	$0(1)	75,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units which vest 25,000 on June 1, 2027, 25,000 on June 1, 2028 and the remainder on June 1, 2029.

	/s/ Umesh Sripad	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did LifeMD (LFMD) report for Sripad Umesh?

LifeMD reported that Chief Technology Officer Sripad Umesh received a grant of 75,000 shares of Common Stock. The award was recorded at a price of $0.00 per share and is structured as a time-vested equity compensation grant.

How many LifeMD (LFMD) shares were granted to the CTO in this Form 4?

The Form 4 shows a grant of 75,000 shares of LifeMD Common Stock to the Chief Technology Officer. These shares are tied to restricted stock units that vest in stages over three years, rather than being purchased on the open market.

What is the vesting schedule for Sripad Umesh’s LifeMD (LFMD) restricted stock units?

The restricted stock units vest in three installments: 25,000 units on June 1, 2027, 25,000 units on June 1, 2028, and the remaining units on June 1, 2029. This creates a multi-year equity incentive for the Chief Technology Officer.

Did Sripad Umesh buy or sell LifeMD (LFMD) shares on the market?

The Form 4 does not show any open-market buying or selling by Sripad Umesh. Instead, it reports a grant or award acquisition of 75,000 shares at a transaction price of $0.00 per share, indicating compensation rather than a market trade.

What are Sripad Umesh’s LifeMD (LFMD) holdings after this Form 4 transaction?

After the reported grant, Sripad Umesh directly holds 75,000 shares of LifeMD Common Stock. These shares are associated with restricted stock units that vest in tranches from June 1, 2027 through June 1, 2029, according to the filing footnote.